BioProcess International is part of the Informa Connect Division of Informa PLC
Informa PLC
|
ABOUT US
|
INVESTOR RELATIONS
|
TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
About
Subscribe
Contribute
Subscribe
Subscribe
Upstream
Related Topics
Bioreactors
Expression Platforms
Biochemicals/Raw Materials
Cell Culture Media
Microbial Cell Culture
Perfusion Cell Culture
See all
Downstream
Related Topics
Filtration
Viral Clearance
Separation/Purification
Chromatography
See all
Manufacturing
Related Topics
Biosimilars
Continuous Bioprocessing
Facility Design/Engineering
Formulation
Single Use
Fill/Finish
Information Technology
Recent in
Manufacturing
See all
Monoclonal Antibody Productivity
Single Use
A Fully Single-Use Downstream Process for Monoclonal Antibodies
A Fully Single-Use Downstream Process for Monoclonal Antibodies
by
Shunsuke Shiina,
Neha Saxena
and 1 more
Apr 17, 2024
Artificial intelligence
Information Technology
Using Artificial Intelligence for Monoclonal Antibody Discovery
Using Artificial Intelligence for Monoclonal Antibody Discovery
by
William Whitford
Apr 17, 2024
Analytical
Related Topics
QA/QC
Cell Line Development
PAT
Product Characterization
Bioanalytical Methods
Process Development
Assays
Recent in
Analytical
See all
Cell-Line
Cell Line Development
Cell-Line Discussions at BPI West 2024
Cell-Line Discussions at BPI West 2024
by
Cheryl Scott
May 10, 2024
Business
Related Topics
Bioregions
Careers & Training
Contract Services
Economics
Pre-Clinical & Clinical Trials
Risk Management
Intellectual Property
Regulatory Affairs
See all
Therapeutic Modalities
Related Topics
Cell Therapies
Gene Therapies
MAb
Emerging Therapeutics
Personalized Medicine
Large Molecule Development
Vaccines
Recent in
Therapeutic Modalities
See all
Sino Biological’s Center for Bioprocessing (C4B) in Houston, TX
Emerging Therapeutics
Recombinant Antibody Technology: Its Criticality to Past and Future Biopharmaceutical Success
Recombinant Antibody Technology: Its Criticality to Past and Future Biopharmaceutical Success
by
Suranjana Sen
Apr 17, 2024
Characterization methodologies
Emerging Therapeutics
Intact and Subunit Molecular Mass Analysis for Development of Antibody Therapeutics: Considerations for Novel Biotherapeutics and Biosimilars
Intact and Subunit Molecular Mass Analysis for Development of Antibody Therapeutics: Considerations for Novel Biotherapeutics and Biosimilars
by
Sanjib Banerjee,
Rajiv Bharadwaj
Apr 17, 2024
BioProcess Insider
Related Topics
Deal-Making
Facilities & Capacity
Global Markets
Regulations
Therapeutic Class
Upstream & Downstream Processing
Webcasts
BioProcess Insider Podcasts
Recent in
BioProcess Insider
See all
thumbnail
Deal Making
Minaris produces first batch of Bluebird's sickle cell therapy
Minaris produces first batch of Bluebird's sickle cell therapy
by
Shreeyashi Ojha
May 10, 2024
2 Min Read
thumbnail
Facilities & Capacity
Solvias breaks ground on NC cell therapy plant
Solvias breaks ground on NC cell therapy plant
by
Shreeyashi Ojha
May 9, 2024
1 Min Read
Home
Webinars
Webinars
Past Webinars
Sponsored Content
Small Format Connections for Optimizing Manufacturing
Small Format Connections for Optimizing Manufacturing
Oct 26, 2022
|
20 Min View
by
BPI Contributor
Sponsored Content
Addressing Purification Challenges for Complex Therapeutics with Custom Chromatography Resins
Addressing Purification Challenges for Complex Therapeutics with Custom Chromatography Resins
Oct 20, 2022
|
20 Min View
by
BPI Contributor
Sponsored Content
Streamlined AAV Manufacture: From Plasmid Design to GMP Production
Streamlined AAV Manufacture: From Plasmid Design to GMP Production
Oct 20, 2022
|
20 Min View
by
BPI Contributor
Global Markets
BioProcess Insider State of the Industry – Live from Biotech Week Boston
BioProcess Insider State of the Industry – Live from Biotech Week Boston
Oct 11, 2022
|
20 Min View
by
BPI Contributor
Sponsored Content
Downstream Process Development for the Purification of Biosimilar Insulin from Escherichia Coli
Downstream Process Development for the Purification of Biosimilar Insulin from Escherichia Coli
Oct 11, 2022
|
20 Min View
by
BPI Contributor
Sponsored Content
Robust and Scalable MAb Capture Facilitated by a Novel Convecdiff Membrane Structure
Robust and Scalable MAb Capture Facilitated by a Novel Convecdiff Membrane Structure
Oct 6, 2022
|
20 Min View
by
BPI Contributor
Sponsored Content
Leveraging Post-Translational Modifications and Bio-Functional Assays for Characterization of Charged Variants
Leveraging Post-Translational Modifications and Bio-Functional Assays for Characterization of Charged Variants
Oct 5, 2022
|
20 Min View
by
BPI Contributor
Webcasts
Testing times: WuXi ATU investments ready to support CGT cascade
Testing times: WuXi ATU investments ready to support CGT cascade
Oct 4, 2022
|
20 Min View
by
BPI Staff